首页 | 官方网站   微博 | 高级检索  
     

视网膜静脉阻塞患者视力预后相关因素分析
作者姓名:Zhang H  Xia Y
作者单位:100083,北京大学第三医院眼科
摘    要:目的研究各型视网膜静脉阻塞患者的视力预后、并发症及视力降低的相关因素.方法视网膜静脉阻塞患者913例(944只眼),年龄15~89岁,平均(52.8±11.9)岁;平均随访时间20.7个月.患者所有临床资料均输入计算机,应用SPSS软件进行统计学处理.结果 (1)按部位分型总干阻塞406只眼,占43.0%;半侧阻塞60只眼,占6.4%;分支阻塞478只眼,占50.6%.(2)按缺血分型944只眼中,缺血型633只眼,占67.1%;非缺血型311只眼,占32.9%.(3)患者视力预后各型静脉阻塞患者治疗前、后视力比较,总干阻塞和半侧阻塞的差异无显著性(t=1.45,1.62;均P>0.05),分支阻塞的差异有显著意义(t=7.89,P<0.05).(4) 患者初诊视力水平与预后3种类型静脉阻塞患者视力预后均差;患者的初诊视力水平均与视力预后密切相关(χ2=175.261,21.357,106.408;均P<0.01).(5) 静脉阻塞导致的低视力和盲目率各型静脉阻塞患者的低视力与盲目率比较,差异有显著意义(χ2=85.251,P<0.01).(6) 缺血型与非缺血型患者视力预后比较视网膜静脉总干阻塞、半侧阻塞、分支阻塞患者中缺血型与非缺血型比较,差异均有显著意义(χ2=157.819,19.637,56.737;P<0.01).(7)导致静脉阻塞的危险因素高血压占57.8%,动脉硬化占67.4%,血液黏稠度增高占24.6%,原发性青光眼占1.5%,糖尿病占6.2%.(8) 静脉阻塞患者并发症的发生率黄斑囊样水肿占46.7%,视网膜和(或)视乳头新生血管占21.5%,玻璃体出血占11.4%,新生血管性青光眼占4.2%.其中总干阻塞发生新生血管性青光眼39只眼,占总干阻塞的9.6%,占半侧阻塞的1.7%.(9)并发症导致的低视力和盲目率低视力者中,黄斑囊样水肿占37.9%,新生血管占29.9%;盲目者中,黄斑囊样水肿占19.5%,新生血管占23.0%.新生血管性青光眼导致的盲目者中,视力<0.05者占95.0%.结论视网膜静脉阻塞的致盲率较高,影响视力预后的最重要因素是缺血型视网膜静脉阻塞.初诊视力水平与视力预后关系密切,黄斑囊样水肿、新生血管及新生血管性青光眼为致盲的重要原因.

关 键 词:视网膜静脉阻塞  并发症  视力预后  相关因素

Analysis of visual prognosis and correlative factors in retinal vein occlusion
Zhang H,Xia Y.Analysis of visual prognosis and correlative factors in retinal vein occlusion[J].Chinese Journal of Ophthalmology,2002,38(2):98-102.
Authors:Zhang Huirong  Xia Yingjie
Affiliation:Department of Ophthalmology, Third Hospital, Beijing University, Beijing 100083, China. huirong@public.fhnet.cn.net
Abstract:OBJECTIVE: To investigate the visual prognosis, risk factors, complications and the causes of visual deterioration in patients with various types of retinal vein occlusion (RVO). METHODS: Nine hundred and forty-four eyes of 913 patients with various types of RVO were analyzed. The age range of patients was 15 - 89 years (average 52.8 +/- 11.9), and the average follow-up was 20.7 months. The data of the patients were studied by SPSS software. RESULTS: (1) RVO was classified into central RVO (CRVO) in 406 eyes of 391 cases (43.0%), hemi-RVO (HRVO) in 60 eyes of 60 cases (6.4%) and branch RVO (BRVO) in 478 eyes of 462 cases (50.6%). (2) They were subdivided into ischemic type in 633 eyes (67.1%) and non-ischemic type in 311 eyes (32.9%). (3) The visual prognosis: the average initial visual acuity (VA) in CRVO, HRVO and BRVO was 0.36, 0.38 and 0.40 respectively. The average final VA was 0.40 in CRVO (P > 0.05), 0.50 in HRVO (P > 0.05) and 0.58 in BRVO (P < 0.05). (4) The initial VA and prognosis: there was close relationship between initial VA and visual prognosis. If the initial VA >/= 0.5, the final acuity maintained >/= 0.5 in 70.6% in CRVO, 75.0% in HRVO and 84.9% in BRVO. The patients with initial VA
Keywords:
本文献已被 万方数据 PubMed 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司    京ICP备09084417号-23

京公网安备 11010802026262号